Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems:a scoping review  

作　　者：Xiyu Shang Yuqing Cao Yang Guo Lei Zhang Jiajia Li Huifang Zhang Yipin Fan Yuxuan Huang Jiantao Li Yanping Wang Yibai Xiong Qiujie Cai Huamin Zhang Yan Ma 

机构地区：[1]Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China [2]Institute of Traditional Chinese Medicine Information,Chinese Academy of Traditional Chinese Medicine,Beijing 100700,People’s Republic of China [3]Fuwai Hospital,Chinese Academy of Medical Sciences,Beijing 100037,China [4]NHC Key Laboratory of Human Disease Comparative Medicine,Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing 100021,China [5]Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China

出　　处：《Infectious Diseases of Poverty》2024年第6期94-95,共2页贫困所致传染病(英文)

基　　金：supported by National Key Research and Development Program of China(2023YFC3503400);Scientifc and technological innovation project of CACMS(CI2021A03703,CI2021A00704,CI2021B003,CI2021A01314);China Academy of Chinese Medical Sciences(2023007);National Natural Science Foundation of China(82274350).

摘　　要：Background Traditional Chinese medicine(TCM)has developed a rich theoretical system and practical experience in fighting to infectious diseases over the past thousands of years,and has played an important role in controlling the spread owing to its unique advantages.In particular,its significant contribution to the prevention and control of Corona Virus Disease 2019(COVID-19)is widely recognized.COVID-19 infection is mainly non-severe with a favorable overall outcome,but patients with comorbidities tend to have a poor prognosis.However,a comprehensive review ofTCM for preventing and treating COVID-19 with comorbidities across various systems is still lacking.Hence,this scoping review aims to conduct a comprehensive investigation on treatment outcome of TCM for treating COVID-19 with comorbidities across various systems.Methods The scoping review was conducted by searching English databases including PubMed and Web of Science,and Chinese databases including China National Knowledge Infrastructure and Wanfang between January 2020 and January 2024.We followed the inclusion and exclusion criteria to identify relevant literature.Information for inclusion in the literature were subsequently extracted and consolidated.Results We enrolled 13 literature that met the inclusion criteria in the review finally.Our analysis revealed that research on COVID-19 with comorbidities was mostly focused on circulatory diseases,including hypertension,heart failure,and cerebrovascular diseases,most common comorbidities were hypertension.Followed by endocrine and metabolic diseases such as diabetes,respiratory diseases including pulmonary tuberculosis and chronic obstructive pulmonary disease have been also addressed.However,there were few studies on co-infectious urogenital system disease,and no studies on the rheumatic,immune,hematological,nervous,reproductive,and skin systems diseases.Based on existing studies,TCM has significantly improved the clinical symptoms of COVID-19 with comorbidities such as fever,fatigue,dry cough,anorexia a

关 键 词：Traditional Chinese medicine COVID-19 COMORBIDITIES Clinical efect Review 

分 类 号：R73[医药卫生—肿瘤]